Subcutaneous Foslevodopa as Rescue Therapy for Abrupt Interruption of Oral Dopaminergic Treatment in Parkinson's Disease.
Subcutaneous Foslevodopa as Rescue Therapy for Abrupt Interruption of Oral Dopaminergic Treatment in Parkinson's Disease.
Where did the research take place?
The study site has not been established. Author addresses may differ from where the research occurred.
Toulouse, FR · Author affiliation
Department of Clinical Pharmacology and Neurosciences, Toulouse Parkinson Expert Centre, Toulouse NeuroToul Center of Excellence in Neurodegeneration (COEN), French NS Park/F-CRIN Network, University of Toulouse 3, CHU of Toulouse, INSERM, Toulouse, France.Location evidence
Limoges, FR · Author affiliation
Department of Neurology, Limoges University Hospital, Inserm, U1094, EpiMaCT Epidemiology of Chronic Diseases in Tropical Zone, Limoges, France.Location evidence
A plain-language reading has not been prepared for this paper yet.